[go: up one dir, main page]

EE200200607A - 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena - Google Patents

2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena

Info

Publication number
EE200200607A
EE200200607A EEP200200607A EEP200200607A EE200200607A EE 200200607 A EE200200607 A EE 200200607A EE P200200607 A EEP200200607 A EE P200200607A EE P200200607 A EEP200200607 A EE P200200607A EE 200200607 A EE200200607 A EE 200200607A
Authority
EE
Estonia
Prior art keywords
antitumor drugs
acylindole derivatives
acylindole
derivatives
antitumor
Prior art date
Application number
EEP200200607A
Other languages
English (en)
Estonian (et)
Inventor
Beckers Thomas
Baasner Silke
Klenner Thomas
Mahboobi Siavosh
Pongratz Herwig
Frieser Markus
Hufsky Harald
Hockemeyer J�rg
Fiebig Heinz-Herbert
Burger Angelika
B�hmer Frank-D
Original Assignee
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000120852 external-priority patent/DE10020852A1/de
Priority claimed from DE2001102629 external-priority patent/DE10102629A1/de
Application filed by Baxter Healthcare Sa filed Critical Baxter Healthcare Sa
Publication of EE200200607A publication Critical patent/EE200200607A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP200200607A 2000-04-28 2001-04-27 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena EE200200607A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2000120852 DE10020852A1 (de) 2000-04-28 2000-04-28 2-Acryl-indolderivate und deren Verwendung als Antitumormittel
DE2001102629 DE10102629A1 (de) 2001-01-20 2001-01-20 2-Acyl-indolderivate und deren Verwendung als Antitumormittel
PCT/EP2001/004783 WO2001082909A2 (de) 2000-04-28 2001-04-27 2-acyl-indolderivate und deren verwendung als antitumormittel

Publications (1)

Publication Number Publication Date
EE200200607A true EE200200607A (et) 2004-04-15

Family

ID=26005501

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200607A EE200200607A (et) 2000-04-28 2001-04-27 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena

Country Status (27)

Country Link
US (2) US20020091124A1 (xx)
EP (1) EP1276720B1 (xx)
JP (1) JP2004501092A (xx)
KR (1) KR20030024661A (xx)
CN (1) CN1286810C (xx)
AR (1) AR029915A1 (xx)
AT (1) ATE348805T1 (xx)
AU (1) AU783459B2 (xx)
BG (1) BG107309A (xx)
BR (1) BR0110414A (xx)
CA (1) CA2407677A1 (xx)
CZ (1) CZ20023544A3 (xx)
DE (1) DE50111690D1 (xx)
EE (1) EE200200607A (xx)
GE (1) GEP20063751B (xx)
HK (1) HK1054549B (xx)
HR (1) HRP20020940A2 (xx)
HU (1) HUP0300480A3 (xx)
IL (1) IL152477A0 (xx)
IS (1) IS6594A (xx)
MX (1) MXPA02010627A (xx)
NO (1) NO20025150L (xx)
NZ (1) NZ522246A (xx)
PL (1) PL358877A1 (xx)
RU (1) RU2002132253A (xx)
SK (1) SK15432002A3 (xx)
WO (1) WO2001082909A2 (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030013433A (ko) 2000-05-31 2003-02-14 아스트라제네카 아베 혈관 손상 활성을 가진 인돌 유도체
US7005445B2 (en) 2001-10-22 2006-02-28 The Research Foundation Of State University Of New York Protein kinase and phosphatase inhibitors and methods for designing them
DE10152306A1 (de) * 2001-10-26 2003-07-24 Asta Medica Ag 2-Acylindolderivate mit neuen therapeutisch wertvollen Eigenschaften
WO2003082271A2 (en) 2002-04-03 2003-10-09 Astrazeneca Ab Indole derivatives having anti-angiogenetic activity
UA78999C2 (en) 2002-06-04 2007-05-10 Wyeth Corp 1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
TW200400177A (en) 2002-06-04 2004-01-01 Wyeth Corp 1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
SE0300908D0 (sv) * 2003-03-31 2003-03-31 Astrazeneca Ab Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
AU2004297235A1 (en) * 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
MXPA06014471A (es) 2004-06-09 2007-03-21 Glaxo Group Ltd Derivados de pirrolopiridina.
US20060074083A1 (en) * 2004-10-05 2006-04-06 Merz Pharma Gmbh & Co. Kgaa Cyclic and acyclic propenones for treating CNS disorders
AU2006212726C1 (en) * 2005-02-14 2013-05-16 Bionomics Limited Novel tubulin polymerisation inhibitors
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
US20060293345A1 (en) * 2005-05-20 2006-12-28 Christoph Steeneck Heterobicyclic metalloprotease inhibitors
US7838542B2 (en) 2006-06-29 2010-11-23 Kinex Pharmaceuticals, Llc Bicyclic compositions and methods for modulating a kinase cascade
FR2950053B1 (fr) * 2009-09-11 2014-08-01 Fournier Lab Sa Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
WO2014033497A1 (en) 2012-08-27 2014-03-06 Centre National De La Recherche Scientifique 5-azaindole compounds with anticancer and antiangiogenic activities
US9353150B2 (en) 2012-12-04 2016-05-31 Massachusetts Institute Of Technology Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
CA2905509A1 (en) 2013-03-15 2014-09-18 Memorial Sloan-Kettering Cancer Center Hsp90-targeted cardiac imaging and therapy
EP3233797B1 (en) * 2015-01-18 2019-05-08 SRI International Inc. Map4k4 (hgk) inhibitors
CN104945376B (zh) * 2015-07-09 2017-03-15 安徽理工大学 一种3‑芳酰基吲哚化合物的合成方法
WO2017197045A1 (en) 2016-05-11 2017-11-16 Movassaghi Mohammad Convergent and enantioselective total synthesis of communesin analogs
CN107722013B (zh) * 2016-08-11 2021-01-12 中国科学院上海药物研究所 去氮嘌呤类化合物及其药物组合物、制备方法和用途
WO2018209239A1 (en) 2017-05-11 2018-11-15 Massachusetts Institute Of Technology Potent agelastatin derivatives as modulators for cancer invasion and metastasis
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
WO2020247054A1 (en) 2019-06-05 2020-12-10 Massachusetts Institute Of Technology Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
US12030888B2 (en) 2021-02-24 2024-07-09 Massachusetts Institute Of Technology Himastatin derivatives, and processes of preparation thereof, and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660430A (en) * 1969-11-04 1972-05-02 American Home Prod 2-substituted-3-arylindoles
US3838167A (en) * 1972-08-01 1974-09-24 Lilly Co Eli Process for preparing indoles
DK3375A (xx) * 1974-01-25 1975-09-15 Ciba Geigy Ag
US5436265A (en) * 1993-11-12 1995-07-25 Merck Frosst Canada, Inc. 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
NZ334344A (en) * 1996-09-12 2000-08-25 Cancer Res Campaign Tech benzo[e]indole and pyrrolo[3,2-e]indole compounds and their use as prodrugs
AP9801302A0 (en) * 1997-07-23 2000-01-23 Pfizer Indole compounds as anti-inflammatory/analgesic agents..

Also Published As

Publication number Publication date
HUP0300480A2 (hu) 2003-06-28
MXPA02010627A (es) 2004-05-17
US20020091124A1 (en) 2002-07-11
CA2407677A1 (en) 2002-10-28
AU783459B2 (en) 2005-10-27
SK15432002A3 (sk) 2004-01-08
KR20030024661A (ko) 2003-03-26
NO20025150L (no) 2002-12-16
US20030158216A1 (en) 2003-08-21
RU2002132253A (ru) 2004-07-10
NZ522246A (en) 2006-01-27
HK1054549A1 (en) 2003-12-05
PL358877A1 (en) 2004-08-23
JP2004501092A (ja) 2004-01-15
CN1286810C (zh) 2006-11-29
ATE348805T1 (de) 2007-01-15
AU6898401A (en) 2001-11-12
BG107309A (bg) 2003-09-30
HK1054549B (zh) 2007-02-23
IL152477A0 (en) 2003-05-29
AR029915A1 (es) 2003-07-23
GEP20063751B (en) 2006-02-27
WO2001082909A3 (de) 2002-03-14
EP1276720B1 (de) 2006-12-20
HUP0300480A3 (en) 2006-04-28
NO20025150D0 (no) 2002-10-25
HRP20020940A2 (en) 2005-02-28
WO2001082909A2 (de) 2001-11-08
CN1431997A (zh) 2003-07-23
EP1276720A2 (de) 2003-01-22
DE50111690D1 (de) 2007-02-01
CZ20023544A3 (cs) 2004-07-14
BR0110414A (pt) 2003-02-11
IS6594A (is) 2002-10-25

Similar Documents

Publication Publication Date Title
EE200200607A (et) 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
EE04565B1 (et) Adamantaani derivaadid, nende saamine ja kasutamine
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
EE201300011A (et) Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina
EE200200064A (et) Arüülmetüülkarbonüülaminotiasooli derivaadid, nende valmistamine ja kasutamine vähivastaste toimeainetena
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
PT1296974E (pt) Derivados 2-cianopirrolidina e sua utilização como medicamentos
EE200300048A (et) Bensimidasooli derivaadid, nende valmistamine ja terapeutiline kasutamine
DK1354888T3 (da) Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter
AR028622A1 (es) Derivados de tropano utiles en terapia
ATE540013T1 (de) Naphthalinderivate
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
EE200300207A (et) Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
EE200200626A (et) Antraniilamiidid ja nende kasutamine ravimitena
EE200100470A (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
EE200100009A (et) Bensimidasoolid, nende valmistamine ja kasutamineravimitena
EE200100391A (et) Peptidüül-heterotsüklilised ketoonid, nende kasutamine ja farmatseutiline kompositsioon
EE200300193A (et) Asendatud bensimidasoolid, nende kasutamine ja ravim
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
NO20022021D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
EE05333B1 (et) Makroliidhendite konjugaadid p?letikuvastaste henditega ja nende kasutamine
TR200002099A3 (tr) Siklobüten türevleri, bunlarin hazirlanmasi ve terapötik kullanimlari
FI20000818A0 (fi) Dermatologinen käyttö ja valmiste